About RYNE Biotechnology
RYNE Biotechnology is a private company based in Cambridge, Massachusetts, incorporated in 2022 in Delaware. It has reported $33,000,000 raised in two offerings on Form D since July 2022. Its chief executive is Nick Manusos.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 26, 2024 | Mar 1, 2024 | $30,000,000of $81.8M target | 9 | $3.3M | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 13, 2022 | Jul 20, 2022 | $3,000,000of $5.0M target | 1 | $3.0M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $33,000,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on RYNE Biotechnology's Form D filed Mar 1, 2024.
JG
Jeff Goater
Director
PF
Peter Fuhrken
Director
HF
Howard Federoff
Executive officer and director
NM
Nick Manusos
CEO and director
DF
David Fallace
Director
JJ
Jeff Jonas
Director
MO
Martin Ostrowski
Executive officer
JY
Jonathan Yeh
Director
Earlier filings also listed Carter Cliff (director, last listed Jul 2022).